IVD Contract Manufacturing Services Market Projections 2025-2030: Key Trends, Opportunities, and Growth Factors in New Report
IVD Contract Manufacturing Services Market Overview:
The global IVD
contract manufacturing services market is projected to grow at a CAGR of
roughly 11% over the forecast period. This expansion is driven by several
factors, including increasing demand for point-of-care (PoC) testing,
government initiatives to scale up IVD kit production post-COVID-19, rising incidence
of cancer and infectious diseases, and the benefits offered by IVD contract
manufacturers—such as cost efficiency, scalability, technical expertise, and
risk mitigation.
Year-End
Mega Sale: Get Up to 10% Off on All Market Research Reports!
In-vitro diagnostics (IVD) involve testing samples such
as blood or tissue to detect diseases or other conditions and to monitor
overall health for prevention, diagnosis, or treatment. OEMs are increasingly
outsourcing to IVD contract development and manufacturing organizations (CDMOs)
to leverage their cost advantages, specialized know-how, scalable operations,
and ability to reduce regulatory and supply-chain risks.
Competitive Landscape Analysis
The IVD Contract Manufacturing Services market is marked
by the presence of key players such as Jabil Inc., STRATEC, Celestica, Sanmina Corporation, Röchling, KMC Systems,
Savyon Diagnostics, Nova Biomedical, Cone Bioproducts, Thermo Fisher Scientific
Inc., Cenogenics Corporation, Coris BioConcept, Gerresheimer, and
Phillips-Medisize, among others. Some of the key
strategies adopted by market players include strategic partnerships and
collaborations and geographic expansion.
Rising preference for point-of-care
testing accelerates market growth
As healthcare systems aim to shorten turnaround times
and empower patients with faster, more accessible results, demand for PoC
diagnostics continues to rise. PoC testing—delivered in hospitals, clinics,
physicians’ offices, or even at home—requires devices with high-precision
components, fluid handling, and reagent processing. These complex manufacturing
needs make specialized IVD CDMOs essential partners for OEMs.
“Rising demand for point-of-care IVD devices is a key
driver for growth. Recently launched PoC instruments are convenient and
efficient, but their design and production present challenges that IVD CDMOs
are uniquely positioned to solve.”
— Director, Leading IVD OEM, United States
Cost savings, scalability, technical
expertise, and risk reduction boost reliance on IVD CDMOs
By collaborating with IVD contract manufacturers, OEMs
reduce labor and automation costs and benefit from economies of scale. CDMOs
also offer advanced technical capabilities that many OEMs do not possess
in-house. Additionally, outsourcing helps mitigate regulatory and supply-chain
risks. Recent partnerships highlight this trend:
- January 2025: Akoya Biosciences selected Argonaut Manufacturing
Services to support production of IVD products, accelerating
commercialization and expanding Akoya’s IVD portfolio.
- March 2024: Beckman Coulter and Fujirebio partnered to
co-develop patient-friendly, blood-based Alzheimer’s tests, utilizing
Fujirebio’s IVD expertise and manufacturing capabilities.
Download Sample Copy: https://meditechinsights.com/ivd-contract-manufacturing-services-market/request-sample/
Growing burden of cancer and
infectious diseases strengthens demand
IVDs are central to cancer screening, diagnosis, and
treatment decisions, providing insights into disease risk, stage, and treatment
response. They are equally critical in infectious disease management—measuring
analyte concentrations, detecting specific biomarkers, and guiding timely
treatment decisions. As cases of cancer and infectious diseases continue to
rise globally, the need for reliable, high-quality diagnostic manufacturing is
expected to intensify, further driving demand for IVD contract manufacturing
services.
Global IVD
Contract Manufacturing Services Market Segmentation
This report by Medi-Tech Insights provides the size
of the global IVD contract manufacturing services market at the regional-
and country-level from 2023 to 2030. The report further segments the market
based on service, technology, and end-user.
Market Size & Forecast (2023-2030), By Service, USD
Million
·
Manufacturing
Services
·
Assay
Development Services
·
Others
Market Size & Forecast (2023-2030), By Technology, USD
Million
·
Immunoassays
·
Clinical
Chemistry
·
Molecular
Diagnostics
·
Hematology
·
Microbiology
·
Coagulation
·
Others
Market Size & Forecast (2023-2030), By End-user, USD
Million
·
Medical
Device Companies
·
Academic
& Research Institutes
·
Others
Market Size & Forecast (2023-2030), By Region, USD
Million
·
North
America
o US
o Canada
·
Europe
o UK
o Germany
o France
o Italy
o Spain
o Rest of Europe
·
Asia
Pacific
o China
o India
o Japan
o Rest of Asia Pacific
·
Latin
America
·
Middle East
& Africa
Browse Report: https://meditechinsights.com/ivd-contract-manufacturing-services-market/
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment